BRIEF published on 06/01/2026 at 17:51, 24 days 14 hours ago HBM Healthcare Investments affiche des performances stables Performance Financière Valeur Nette D'actif Marché Suisse Investissements HBM Dans Le Secteur De La Santé Croissance Du Cours De L'action
PRESS RELEASE published on 06/01/2026 at 17:46, 24 days 14 hours ago Key Figures 31.05.2026 HBM Healthcare Investments AG reports key figures for May 2026, showing NAV at 287.92 CHF with a 2.5% CYTD performance. Share price at 238.00 CHF with 5.1% performance CYTD Financial Performance HBM Healthcare Investments AG Key Figures CHF May 2026
BRIEF published on 06/01/2026 at 08:38, 24 days 23 hours ago HBM Healthcare finalise l'acquisition de Swixx Biopharma Bain Capital Swixx BioPharma HBM Healthcare Croissance Biopharmaceutique SK CAPITAL
BRIEF published on 06/01/2026 at 08:38, 24 days 23 hours ago HBM Healthcare Completes Swixx Biopharma Transaction Bain Capital Swixx BioPharma HBM Healthcare Biopharmaceutical Growth SK CAPITAL
PRESS RELEASE published on 06/01/2026 at 08:33, 24 days 23 hours ago HBM Healthcare Investments Announces Closing of Swixx Biopharma Transaction with SK Capital and Bain Capital Life Sciences HBM Healthcare Investments successfully closes Swixx Biopharma transaction with SK Capital and Bain Capital Life Sciences, remaining a significant shareholder Acquisition HBM Healthcare Investments Swixx BioPharma SK CAPITAL Bain Capital Life Sciences
BRIEF published on 05/26/2026 at 13:15, 30 days 18 hours ago Eli Lilly to Acquire Curevo Vaccine for Up to USD 1.5 Billion Biotechnology HBM Healthcare Eli Lilly Acquisition Curevo Vaccine Shingles Prevention
BRIEF published on 05/26/2026 at 13:15, 30 days 18 hours ago Eli Lilly va acquérir le vaccin Curevo pour un montant pouvant atteindre 1,5 milliard de dollars américains. Biotechnologie HBM Healthcare Acquisition D'Eli Lilly Vaccin Curevo Prévention Du Zona
PRESS RELEASE published on 05/26/2026 at 13:10, 30 days 19 hours ago Eli Lilly to Acquire HBM Portfolio Company Curevo for up to USD 1.5 Billion Eli Lilly to acquire HBM portfolio company Curevo for up to USD 1.5 billion, boosting HBM Healthcare Investments' net asset value. Curevo focuses on developing vaccines for infectious diseases Acquisition HBM Healthcare Investments Eli Lilly Vaccines Curevo
BRIEF published on 05/18/2026 at 17:52, 1 month 7 days ago HBM Healthcare Investments AG Releases Key Figures for May 2026 Financial Performance Net Asset Value Share Price Investment Risks HBM Healthcare
BRIEF published on 05/18/2026 at 17:52, 1 month 7 days ago HBM Healthcare Investments AG publie ses principaux chiffres pour mai 2026 Performance Financière Valeur Nette D'actif Prix De L'action Risques D'investissement HBM Healthcare
Published on 06/26/2026 at 01:40, 6 hours 32 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 8 hours 42 minutes ago Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 9 hours 42 minutes ago Fountain Asset Corp. Provides Corporate Update
Published on 06/25/2026 at 21:32, 10 hours 40 minutes ago BlackBerry Announces Election Results for the Company's Board of Directors
Published on 06/25/2026 at 15:30, 16 hours 42 minutes ago Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation
Published on 06/26/2026 at 08:00, 12 minutes ago MHM Corporate: Debt Restructuring through Bonds Redeemable in Shares
Published on 06/26/2026 at 08:00, 12 minutes ago MHM Corporate: Restructuration de sa dette par voie d'obligations remboursables en actions
Published on 06/26/2026 at 07:30, 42 minutes ago REINET INVESTMENTS S.C.A. ANNOUNCES REVISED DATE FOR ANNUAL GENERAL MEETING
Published on 06/26/2026 at 07:30, 42 minutes ago THE NAGA GROUP AG CONFIRMS FY 2025 REVENUES AND REPORTS STRONGER-THAN-EXPECTED EBITDA
Published on 06/26/2026 at 07:30, 42 minutes ago Pyrum Innovations AG reports results for the first three months of 2026
Published on 06/26/2026 at 07:00, 1 hour 12 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 1 hour 12 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 13 hours 27 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 13 hours 42 minutes ago Avis financier semestriel SIEHM au 30 avril 2026
Published on 06/25/2026 at 17:50, 14 hours 22 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
